1.66

2.92% -0.05

After Hours: 1.70 0.04 +2.41%

Sunshine Biopharma Inc (SBFM)

Overview News Price History Financials Discussions Forecast Stock Split

Sunshine Biopharma Inc stock is traded at $1.66, with a volume of 23,375. It is down -2.92% in the last 24 hours and down -18.63% over the past month. Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

Previous Close:

$1.71

Open:

$1.71

24h Volume:

23,375

Relative Volume:

0.02

Market Cap:

$3.53M

Revenue:

$35.49M

Net Income/Loss:

$-6.04M

P/E Ratio:

-0.1275

EPS:

-13.0191

Net Cash Flow:

$-6.42M

1W Performance:

-7.78%

1M Performance:

-18.63%

6M Performance:

-86.50%

1Y Performance:

-89.29%

1-Day Range:

$1.66

$1.76

1-Week Range:

$1.66

$1.88

52-Week Range:

$1.66

$24.30

Sunshine Biopharma Inc Stock (SBFM) Company Profile

Name

Sunshine Biopharma Inc

Sector

Healthcare (1071)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

954-330-0684

Address

333 LAS OLAS WAY, FORT LAUDERDALE

Employee

Twitter

Next Earnings Date

2026-08-11

Latest SEC Filings

SBFM's Discussions on Twitter

Compare SBFM vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SBFM Sunshine Biopharma Inc	1.66	3.63M	35.49M	-6.04M	-6.42M	-13.02
TAK Takeda Pharmaceutical Co Adr	17.24	53.71B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.78	42.76B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	30.81	36.31B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	75.35	31.26B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	528.47	26.37B	3.17B	1.29B	1.01B	27.09

Sunshine Biopharma Inc Stock (SBFM) Latest News

Jul 22, 2026

Price to sales forward of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView

Jul 22, 2026

Jul 21, 2026

Sunshine Biopharma Announces ATM Equity Sales Agreement - The Globe and Mail

Jul 21, 2026

Jul 20, 2026

Sunshine Biopharma plans up to $4 million at-the-market share sale via Aegis Capital - Bitget

Jul 20, 2026

Sunshine BiopharmaEnters At-The-Market Sales Agreement With Aegis Capital For Up To $4 MillionSEC Filing - TradingView

Jul 20, 2026

Sunshine Biopharma announces publication of new results on MR1-114 - TipRanks

Jul 20, 2026

Sunshine Biopharma (SBFM) Reports Breakthrough Research on SARS-CoV-2 Treatment - GuruFocus

Jul 20, 2026

Sunshine Biopharma and University of Arizona Publish Significant New Research Findings - The Daily Corinthian

Jul 20, 2026

Sunshine Biopharma's Novel Inhibitor Matched Nirmatrelvir in Mice - Stock Titan

Jul 20, 2026

Jul 16, 2026

Form DEF 14A Sunshine Biopharma Inc For: 16 July By Investing.com - Investing.com Canada

Jul 16, 2026

Jul 14, 2026

Sunshine Biopharma (SBFM) Eases 1.5% as Stock Tests Support Near $1.82Market Cap Weight - dars.gov.et

Jul 14, 2026

Jul 12, 2026

Sunshine Biopharma stock rallies on Canadian approval for generic amoxicillin - MSN

Jul 12, 2026

Jul 11, 2026

Sunshine Biopharma Settles Dispute With Former Nora President - The Globe and Mail

Jul 11, 2026

Jul 10, 2026

Sunshine Biopharma (NASDAQ: SBFM) pays CAD$1.5M to settle Nora Pharma dispute - Stock Titan

Jul 10, 2026

Jul 09, 2026

Sunshine Biopharma (SBFM) Posts Modest Gain Amid Narrow Trading RangeHead and Shoulders - dars.gov.et

Jul 09, 2026

Jul 08, 2026

Alta Partners LLC reports 200,000 shares in Sunshine Biopharma (SBFM) - Stock Titan

Jul 08, 2026

Jul 07, 2026

Sunshine Biopharma Company Profile & Introduction - Moomoo

Jul 07, 2026

Enterprise value to EBITDA forward of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView

Jul 07, 2026

Jul 06, 2026

Enterprise value to EBIT forward of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView

Jul 06, 2026

Jul 05, 2026

Price to earnings forward of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView

Jul 05, 2026

Jul 04, 2026

Sunshine Biopharma(SBFM) Stock Options Chain | Quotes & News - Moomoo

Jul 04, 2026

Jul 02, 2026

Sunshine Biopharma (SBFM) Dips 3.2% as Stock Nears Key Support at $2.00IV Rank - dars.gov.et

Jul 02, 2026

SBFM Q1 2026 Earnings: Pre-Revenue Biopharma Reports Net Loss Per Share of -$0.25Trough Earnings Signal - DonanımHaber

Jul 02, 2026

Jun 28, 2026

Sunshine Biopharma (SBFM) Edges Higher, Nears Resistance at $2.29Island Reversal - dars.gov.et

Jun 28, 2026

Jun 26, 2026

Sunshine Biopharma Inc. Q1 2026 Earnings: Narrowing Loss Reflects Ongoing Pipeline ProgressCFO Commentary Report - dars.gov.et

Jun 26, 2026

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R) - Black Hills Pioneer

Jun 26, 2026